» Articles » PMID: 28587082

Natural Products As Alternative Choices for P-Glycoprotein (P-gp) Inhibition

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2017 Jun 8
PMID 28587082
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In this review, we discuss MDR in relation to P-glycoprotein (P-gp) and its down-regulation by natural bioactive molecules. P-gp, a unique ATP-dependent membrane transport protein, is one of those key regulators which are present in the lining of the colon, endothelial cells of the blood brain barrier (BBB), bile duct, adrenal gland, kidney tubules, small intestine, pancreatic ducts and in many other tissues like heart, lungs, spleen, skeletal muscles, etc. Due to its diverse tissue distribution, P-gp is a novel protective barrier to stop the intake of xenobiotics into the human body. Over-expression of P-gp leads to decreased intracellular accretion of many chemotherapeutic agents thus assisting in the development of MDR. Eventually, the effectiveness of these drugs is decreased. P-gp inhibitors act by altering intracellular ATP levels which are the source of energy and/or by affecting membrane contours to increase permeability. However, the use of synthetic inhibitors is known to cause serious toxicities. For this reason, the search for more potent and less toxic P-gp inhibitors of natural origin is underway. The present review aims to recapitulate the research findings on bioactive constituents of natural origin with P-gp inhibition characteristics. Natural bioactive constituents with P-gp modulating effects offer great potential for semi-synthetic modification to produce new scaffolds which could serve as valuable investigative tools to recognize the function of complex ABC transporters apart from evading the systemic toxicities shown by synthetic counterparts. Despite the many published scientific findings encompassing P-gp inhibitors, however, this article stand alones because it provides a vivid picture to the readers pertaining to Pgp inhibitors obtained from natural sources coupled with their mode of action and structures. It provides first-hand information to the scientists working in the field of drug discovery to further synthesise and discover new P-gp inhibitors with less toxicity and more efficacies.

Citing Articles

Predictions of the Biological Effects of the Main Components of Tarragon Essential Oil.

Pujicic A, Popescu I, Dascalu D, Petreus D, Isvoran A Int J Mol Sci. 2025; 26(5).

PMID: 40076487 PMC: 11899843. DOI: 10.3390/ijms26051860.


Towards Improved Bioavailability of Cereal Inositol Phosphates, -Inositol and Phenolic Acids.

Zyla K, Duda A Molecules. 2025; 30(3).

PMID: 39942756 PMC: 11820786. DOI: 10.3390/molecules30030652.


Herbal drug‑based nanotherapy for hepatocellular carcinoma: Quercetin‑contained nanocarrier as a multipurpose therapeutic agent against hepatocellular carcinoma (Review).

Batsukh T, Tsend-Ayush A Biomed Rep. 2024; 22(2):29.

PMID: 39720296 PMC: 11668132. DOI: 10.3892/br.2024.1907.


A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy.

Sinanian M, Rahman A, Elshazly A, Neely V, Nagarajan B, Kellogg G Int J Mol Sci. 2024; 25(21).

PMID: 39518898 PMC: 11545213. DOI: 10.3390/ijms252111346.


Soloxolone -3-(Dimethylamino)propylamide Restores Drug Sensitivity of Tumor Cells with Multidrug-Resistant Phenotype via Inhibition of P-Glycoprotein Efflux Function.

Moralev A, Salomatina O, Salakhutdinov N, Zenkova M, Markov A Molecules. 2024; 29(20).

PMID: 39459307 PMC: 11510211. DOI: 10.3390/molecules29204939.


References
1.
van Helvoort A, Smith A, Sprong H, FRITZSCHE I, Schinkel A, Borst P . MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 1996; 87(3):507-17. DOI: 10.1016/s0092-8674(00)81370-7. View

2.
Sun L, Chen W, Qu L, Wu J, Si J . Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression. Mol Med Rep. 2013; 8(6):1883-7. DOI: 10.3892/mmr.2013.1742. View

3.
Wilson C, Volkman S, Thaithong S, Martin R, Kyle D, Milhous W . Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol. 1993; 57(1):151-60. DOI: 10.1016/0166-6851(93)90252-s. View

4.
Lechner D, Gibbons S, Bucar F . Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother. 2008; 62(2):345-8. DOI: 10.1093/jac/dkn178. View

5.
Wang F, Wang L, Yang J, Nomura M, Miyamoto K . Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. Biol Pharm Bull. 2005; 28(10):1979-82. DOI: 10.1248/bpb.28.1979. View